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Objective: To review recent literature on graft materials used in vaginal pelvic floor
surgery. Methods: A Pubmed-search (banterior vaginal wallQ or bcystoceleQ),
(bposterior vaginal wallQ or brectoceleQ) and (bvaginal vaultQ or bpelvic prolapseQ)
and (bmeshQ or berosionQ or bgraftQ or bsyntheticQ) from 1995 to 2005 was performed;
recent reviews [Birch C. The use of prosthetics in pelvic reconstructive surgery. Best
Pract Res Clin Obstet Gynaecol 2005;19:979—91 [1]; Maher C, Baessler K. Surgical
management of anterior vaginal wall prolapse: an evidence-based literature review.
Int Urogynecol J Pelvic Floor Dysfunct 2005 (May 25) [Electronic Publication] [2];
Maher C, Baessler K. Surgical management of posterior vaginal wall prolapse: an
evidence-based literature review. Int Urogynecol J Pelvic Floor Dysfunct
2006;17:84—8 [3]; Altman D, Mellgren A, Zetterstrom J. Rectocele repair using
biomaterial augmentation: current documentation and clinical experience. Obstet
Gynecol Surv 2005;60:753—60 [4] were added. Result: There are few prospective
randomized trials that prove the benefit of implanting grafts in vaginal pelvic floor
surgery. Many articles are retrospective case series with small sample sizes or
incomplete outcome variables. Serious complications such as erosions are often not
mentioned. Inconsistent or unclear criteria for anatomic cure make it difficult to
compare outcomes. Quality of life issues such as dyspareunia, urinary or bowel
symptoms are often ignored. Conclusion: Due to a lack of well-designed prospective
randomized trials, recommendations for using graft materials in vaginal reconstruc-
tive surgery cannot be made. At this time, grafts should have limited use in a
carefully selected patient population.
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Annually, approximately 300,000 American women
suffering from pelvic floor disorders require surgery
[5]. No data was available for estimates of surgery
worldwide. Around one third of these procedures
are for recurrent disease [6]. Thus, it has become
increasingly important to improve surgical strate-
gies to decrease the incidence of surgical failure
and recurrent prolapse.
Recently, the use of surgical mesh in pelvic
floor surgery has become increasingly popular.
While general surgeons have had decades of
experience using mesh in hernia surgery, the
design and development of grafts in gynecologic
procedures is still ongoing. Many materials have
been used without proper trials and are recom-
mended by manufacturers rather than from data
showing long-term improvement of patients’
symptoms or decreased recurrence rates. The
increasing variety of available materials combined
with a paucity of well-conducted clinical trials
make the choice of whether to use grafts or which
one to use difficult. Therefore, it is the aim of this
article to present a critical overview on the use of
grafts for vaginal reconstructive surgery. Sacrocol-
popexy and urethral slings will not be addressed as
there are already excellent reviews in the pub-
lished literature [7,8].2. Classification
It is first important to understand the molecular
and biomechanical properties differences between
different grafts prior to graft selection. Grafts
differ in composition (monofilament vs. multifila-
ment), pore size, flexibility [9], architecture (knit-
ted or woven) and whether they are synthetic or
biological. The ideal graft material should be
chemical inert, non-toxic, non-allergic, non-in-
flammatory, resistant to infection, non-carcinogen-
ic, solid, sterilizable, convenient and affordable
[10,11].Table 1 Amid classification [12]
1 2 3
Macroporous Microporous Macro
N75 nm b10 nm
Examples
Atrium Gore-Tex Mersil
Marlex Surgip
Prolene PTFE
TrelexA standardized classification system has been
proposed to distinguish between the different types
of synthetic mesh shown in Table 1.
Pore size determines migration and infiltration
of macrophages and leucocytes into the graft site
to prevent infection. Fibroblasts, new blood vessel
formation and collagen fibers also require a large
enough pore size to be able to migrate into new
materials. Rejection of materials with small pore
size such as nylon has been reported [13]. Pore
sizes also influence mechanical properties such as
stiffness. Meshes with smaller pore sizes are stiffer
increasing the likelihood of erosion, pain, and poor
function. Tape flexibility or low stiffness is at least
one of the reasons for the outstanding success of
the Gynecare tension-free vaginal tape (TVT)
(polypropylene tape, pore size N75 nm) in terms
of graft erosion [14].
Complications from synthetic materials have led
to an increased use of biomaterials in pelvic
reconstructive surgery. These can be divided into
allografts (human donor), autografts (self donor)
and xenografts (animal donor). Of these, porcine
xenografts such as small intestinal submucosa (SIS,
Cook Biotech, Inc., West Lafayette, IN, USA) or
dermis (Pelvicol/Pelvisoft, C.R. Bard, NJ, USA) are
the most popular. How these biomaterials compare
to synthetics in terms of surgical outcomes has not
been well studied.
More recently, absorbable materials have been
developed which mimic some behaviors of syn-
thetics and biological materials. Polyglactin 910
retains at least 25% of its strength beyond 21 days
in vivo [15]. Vypro (Johnson and Johnson, USA)
appears to be a combination of absorbable poly-
glactin 910 and polypropylene.3. Indications
This section has been organized into the following
headings: anterior wall repair; posterior wall
repair; combined anterior and posterior wall; and
vaginal vault prolapse repair.4
porous/Microporous Submicronic pores
ene (woven Dacron) Silastic
ro (woven Polypropylene) Cellgard
(Teflon)
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that there is no accepted definition for anatomical
cure. Therefore, bcureQ is often defined using
different standards by different authors making
comparison of success rates complicated. Another
difficulty of comparing studies is that functional
outcomes such as sexual, urinary, or bowel function
are not universally reported, and validated ques-
tionnaires are rarely used. It is also important to
take into account de novo adverse symptoms or
complications such as dyspareunia, urinary urgency,
graft infection or erosion. One should not sacrifice
quality of life and functional outcomes for optimal
anatomic results.4. Anterior vaginal wall—cystocele
repair
4.1. Synthetic meshes
The anatomic cure rate for anterior colporrhaphy
using graft materials ranges from 42% to 100%.
While the majority of the reported literature
consists of retrospective case series, Weber et al.
[16] designed a randomized controlled trial on 114
women with anterior wall prolapse. Patients were
assigned to standard anterior colporrhaphy (n =39),
ultralateral colporrhaphy (n =35) and anterior wall
repair with polyglactin 910-mesh (n =35, Vicryl,
Ethicon, Somerville, NJ, USA). Power calculation
was performed, number of patients per group was
estimated to be 31 (power of at least 80%, chance
of type I error limited to 5%). Their mean age was
64.7F11.1 years. All patients were evaluated
after 6 months, 1 and 2 years (mean follow-up
23.3 months) by a blinded research nurse experi-
enced in POP-Q examinations [17]. The three
techniques provided similar anatomic cure rates
(Stages 0, 1: 30%, 46%, 42%, respectively) suggest-
ing no advantage to the addition of the synthetic
grafts in anterior repair. There was one case of
mesh erosion (2.9% of n =35) which required
surgical treatment. Groups also had similar out-
comes for urinary symptoms, voiding, and sexual
function.
Yan et al. [18] prospectively enrolled 30 patients
undergoing cystocele repair using polypropylene
(n =27) , Vypro (n =1, Ethicon, Somerville, NJ, USA)
and polyester (n =3). At mean follow-up (6.7
months, range 2—12) the anatomical success rate
of all patients was reported 97% (stage 0 or stage I).
Mesh erosion occurred in two patients (7%); four
patients complained of persistent urge inconti-
nence (13%); and three developed de novo urgeincontinence (10%). Sexual function was reported
as improved in three (21%), and decreased in five
(36%) with a 36% rate of dyspareunia.
Rodriguez et al. [19] conducted a prospective
study of 98 patients with stage II—IV cystocele
associated with concomitant lateral and apical
defects. They used a transvaginal paravaginal
approach by attaching a piece of polypropylene
mesh to the uterosacral ligaments, the bladder
neck and the obturator fascia. Postoperative POP-Q
assessments showed 85% of patients with stage 0—I
support though length of follow-up is not reported.
There was a 3% rate of de novo stress and urge
urinary incontinence. Patients reported overall
improvement in quality of life due to genitourinary
symptoms (p b0.005, Incontinence Symptom Score,
ISS). No erosions were reported.
Flood et al. [20] reviewed their experience
with 142 patients undergoing a modified anterior
colporrhaphy with polypropylene mesh. Mean age
was 65 years, average parity 2.6. No recurrent
anterior vaginal prolapse beyond stage II was
found with mean follow-up of 3.2 years. Howev-
er, there were three cases of erosions (2.1%) that
required surgery and five patients complained of
dyspareunia.
In contrast to other retrospective series, Cronje
et al. [21] showed a high rate of recurrence
anterior wall prolapse (28.6%) using Vypro mesh
(Johnson and Johnson, Brussels, Belgium) on 28
patients undergoing anterior colposuspension. Uri-
nary retention was also reported in 7.1% leading
the authors to conclude that mesh should not be
recommended in cystocele repair.
All reviewed articles of this section are listed in
Table 2.4.2. Biological materials
Gandhi et al. [29] conducted a prospective, ran-
domized trial of anterior colporrhaphy on 154
patients with or without the use of cadaveric fascia
lata (n =76 vs. v =78, Tutoplast, Mentor Corpora-
tion, Santa Barbara, CA). bFailureQ was defined as
stage II anterior wall prolapse. Recurrent anterior
vaginal wall prolapse occurred in 21.0% of those
with graft vs. 29.0% of those without graft (median
follow-up of 13 months, range 1.4—50, p =0.229)
suggesting no surgical improvement with the use of
the graft. No major complications were reported.
Other studies have found success rates of 83—100%
using cadaveric fascia lata [30,31].
One study reported a 84.2% success rate using
cadaveric dermal allograft with a 5.3% rate of both
de novo urge and infection requiring removal [32].
Table 2 Synthetic mesh used on anterior wall surgery
Author n/n at
follow-up
Used material Mean
follow-up
(months)
Cure rate,
anat.
stage 0, 1
Adverse
effects
Erosion
Weber et al., 2001 [16] 114/109 Polyglactin
910 (n =35)
23.3 42% DND 5.0%
(SA 38%),
DNU 26%,
DNUI 14.0%,
DNSUI 8.0%
2.9% ST
Yan et al., 2004 [18] 30 Polypropylene,
Vypro,
Polyester
6.7 97% DYS 16.7%
(due to ant.
wall, SA 47%),
DNUI 10%
6.7% ST
Rodriguez et al., 2005 [19] 98 Polypropylene Not
reported
85% DNUI 3.1%,
DNSUI 3.1%,
one bladder
wall haematoma
0%
Flood et al., 1998 [20] 142/140 Polypropylene 38.4 100% DYS 3.6% 2.1% ST
Cronje et al., 2004 [21] 28 Vypro 5 81% UR 7.1%
De Tayrac et al., 2002 [22] 48 Polypropylene 18 97.9% 8.3%
Palma et al., 2005 [23] 15 Polypropylene 3 100%
de Tayrac et al., 2005 [24] 87/84 Polypropylene 24 91.6% 8.3%, 4.8% ST
Bader et al., 2004 [25] 40 Polypropylene 16.4 95% 7.5% 2.5% ST
Migliari et al., 2000 [26] 12 Polypropylene 20.5 75% DND 8.3%,
DNU 16.7 %
0%
Migliari et al., 1999 [27] 15 60% Polyglactin 910,
40% Polyester
23.4 93% DND 20% 0%
Julian et al., 1996 [28] 24 Polypropylene (n =12) 24 100% 25% bmesh
related
complicationsQ
DND: de novo dyspareunia, DYS: dyspareunia (general), SA: sexually active, DNU: de novo urgency, DNUI: de novo urge
incontinence, DNSUI: de novo stress urinary incontinence, UR: urinary retention, ST: surgically treated.
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a 93.1% success using Pelvicol (C.R. Bard, NJ, USA)
[33], and a 87.1% success rate using Intexen [34]
(AMS, Minnetonka, MN, USA). Listed in Table 3 are
the studies using biological materials on anterior
wall surgery.Table 3 Biological mesh used on anterior wall surgery
Author n/n at
follow-up
Used material
Gandhi et al., 2005 [29] 154/153 Cadaveric fascia lata
(n =76) no patch (n =78
Frederick et al., 2005 [30] 295/251 Cadaveric sling
Groutz et al., 2001 [31] 21 Cadaveric fascia lata
Chung et al., 2002 [32] 19 cadaveric dermal
allograft
Leboeuf et al., 2004 [33] 43 24 four-defect repair,
19 FDR and Pelvicol
Gomelsky et al., 2004 [34] 70 Porcine, Intexen, AMS
Clemons et al., 2003 [35] 33 AlloDerm graft
Salomon et al., 2004 [36] 27 Pelvicol5. Posterior vaginal wall—rectocele
repair
In an attempt to reduce the risk of rectocele
recurrence, a variety of graft materials and meshes
have been employed to try and strengthen vaginalMean
follow-up
(months)
Cure rate,
anat. stage 0, 1
Adverse effects
)
13 79% vs. 71% No major
6 93% cystocele
repair
20 100%
28 84% 1 infection with removal
15 100% vs. 93.1% No major
24 87.1% Recurrent vault prolapse
2%, de novo rectoceles
8.6%
18 59% 1 febrile morbidity,
1 cystotomy, 1 anterior
wall breakdown
14 81% Removal in 1 case (4%)
due to persistent pain
Table 4 Posterior wall surgery
Author n/n at
follow-up
Used material Mean
follow-up
(months)
Cure rate,
anat.
stage 0, 1
Adverse effects Erosion
Lim et al., 2005 [38] 90/31 Vypro II 6 83.9% CON 18%, DD 20.5,
SVB 15.4%, DND 3.4%
12.9%
Oster et al., 1981 [39] 15 Autologous
dermis
31.2 100% IN 6,7%, CON 33%,
DYS 20%
Kohli et al., 2003 [37] 43/30 Dermal allograft 12.9 93% 0%
Altman et al., 2005 [40] 32/29 Pelvicol 12 62% DD 45%
De Tayrac et al., 2005 [41] 26/25 Polypropylene 22.7 96% DND 7.7%, DD 10% 12%, ST 8%
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have also been used including traditional trans-
vaginal colporrhaphy, defect directed approach
[37] as well as a transperineal approach. There
are no randomized trials comparing graft versus no
graft in isolated posterior defects.
5.1. Synthetic meshes
More recently, other retrospective series have
been published describing the use of synthetic
mesh in transvaginal repairs. The largest series
from Lim et al. [38] uses Vypro II mesh (poly-
glactin/polypropylene, Ethicon, Hamburg, Ger-
many). They conducted a retrospective chart
review on 90 patients with 6-month follow-up data
on 31 patients. Of the 31 patients, there was an
83.9% anatomic cure rate although the criteria
used were not described. This group was also found
to have a vaginal erosion rate of 12.9%. Of the
original 90 patients, 78 returned questionnaires
about pre-operative and postoperative symptoms
which showed postoperative 18% had difficulty
with constipation, 20.5% difficulty with defeca-
tion, 15.4% with sensation of vaginal bulge and a
3.4% de novo dyspareunia rate of 59 patients who
were sexually active.
5.2. Biological materials
Synthetic mesh placement in the posterior wall can
lead to loss of flexibility of the vagina and
restriction of the rectum such that it cannot
expand during evacuation or coitus leading to fecal
urgency and dyspareunia. Therefore, a few studies
have used biologic materials to reinforce posterior
repairs. Oster and Astrup [39] reported in 1981 the
first retrospective case series using dermal auto-
graft for the repair of blargeQ rectoceles in fifteen
patients. Patients were followed from 1 to 4 years
with a mean of 2.6 years. No patients had rectocele
recurrence, one had a post-operative vaginal
infection, five had constipation, and three patients
complained of dyspareunia.Kohli and Miklos performed [37] defect directed
repairs with the placement of cadaveric dermal
grafts over a 1-year period. Thirty women were
followed for an average of 12.9 months. No
patients reported dyspareunia and 2 of 30 or 7%
of patients had an anatomical failure with the
posterior wall at 0.5 cm or greater below the
hymen.
In contrast, another study by Altman et al. [40]
using collagen mesh (Pelvicol, C.R. Bard, NJ, USA)
had less satisfactory results. By 12 months, 11 of 29
patients (38%) had recurrent rectoceles that were
zStage II. Although there was statistically signifi-
cant improvement in symptoms, 45% of patients
continued to have difficulty with rectal emptying
and 17% continued to have to digitally empty the
rectum postoperatively. Neither of these studies
had major intraoperative or postoperative compli-
cations such as graft infection, erosion, or fistula
formation. While this suggests that biological
meshes may be safer with less erosions when
compared to synthetics, prospective, randomized
trials are needed to evaluate their effect on
defecation and sexual function as well as improved
long term reduction in recurrences. Table 4 shows
the reviewed studies of this section.6. Combined procedures—cystocele and
rectocele repair
6.1. Synthetic meshes
Sand et al. [15] performed a prospective random-
ized trial with a sample of 160 women with anterior
wall prolapse to the hymen or beyond. All patients
were randomly assigned to anterior and/or poste-
rior repair either with or without polyglactin 910
mesh (Vicryl mesh, Ethicon, Somerville, NJ, USA)
(n =80 vs. n =80). The two groups did not differ
significantly in age (62.5 vs. 65.0 years), weight,
parity, or estrogen status. 17 patients were lost for
follow-up. The remaining 143 were available for
M. Huebner et al.284the follow-up evaluation (mean 12 months). The
anatomical success rate after 12 months (stages 0,
1) for cystocele repair was significant improved in
the group that received the polyglactin 910 (75%)
compared to the group that achieved normal repair
(57%) (p =0.02). However, no significant difference
was found between groups for the rectocele repair
(mesh: 91.2%, no mesh 90.0%, p =0.71). No cases of
erosion occurred in this study. Functional outcome
was not described.
Milani et al. [42] recruited 63 women for a
prospective observational study using polypropyl-
ene mesh (Prolene Ethicon, Somerville, NJ, USA)
for both anterior and posterior repairs (n =32 with
cystocele repair, n =31 with rectocele repair).
Anatomic cure rate was high in both groups
(anterior repair stage 0: 93.8%, stage 1: 6.2%,
posterior repair stage 0: 93.8%, stage 1: 0%, stage
2: 6.2%). In the anterior repair group urinary
symptoms did not change postoperatively though
mesh erosion occurred in 13%. In the posterior
group there was one case of de novo fecal
incontinence, 6.5% of mesh erosion rate and one
pelvic abscess. They also reported a high rate of
post-operative dyspareunia at 69% (pre-operatively
6%). Despite their good anatomic results, the
authors recommended abandoning the use of
prosthetic material in prolapse surgery due to the
high risk of dyspareunia and mesh erosion.
The largest retrospective case series was by
Cosson et al. [43,44], describing a new technique
using the Prolift mesh (Gynecare, France) for
anterior and posterior vaginal wall prolapse repair
in 687 women. Cystocele repair was performed by a
transversally attached mesh through the obturatorTable 5 Synthetic mesh used on anterior and posterior w
Author n/n at
follow-up
Used material Mean
follow-
(month
Sand et al., 2001 [15] 161/143 Polyglactin 910 12
Milani et al., 2004 [42] 63 Polypropylene 17
Cosson et al., 2005 [44] 687 Prolift 3.6
Dwyer et al., 2004 [45] 97 Polypropylene 29
Adhoute et al., 2004 [46] 52 Polypropylene 27
Borrell Palanca
et al., 2004 [47]
31 Polypropylene 23.5
Canepa et al., 2001 [48] 16 Polypropylene 24.3
DND: de novo dyspareunia, IN: Infection, DYS: dyspareunia (genera
urgency, UR: urinary retention, ST: surgically treated.foramen, rectocele repair by adding a posterior
mesh anchored through the sacrospinous ligaments.
Unfortunately, the follow-up time was only 3.6
months making their success rate of 94.7% unreli-
able. During this period, they reported a 6.7% rate
of granuloma formation or vaginal erosion which
needed surgically treatment and a 5.4% rate of de
novo stress urinary incontinence.
Dwyer et al. [45] performed a retrospective
analysis of polypropylene mesh (Atrium, Hudson,
New Hampshire, USA) in anterior, posterior and
combined prolapse repair in 97 patients. Their
anatomical results varied from 91.5% (anterior
repair), 93.9% (posterior repair) and 88.2% (com-
bined surgery). The reported improved functional
outcomes postoperatively for SUI (34.2%), urge
(38.0%), urge incontinence (32.1%), constipation
(19.1%), dyspareunia (11.5%) and voiding difficulty
(37.1%). However, they also had complications
including mesh erosion (9.0%) and one case of
rectovaginal fistula.
We could find no series using biological materials
in combination for anterior and posterior wall
prolapse.
Table 5 shows the studies using synthetic mesh in
combined surgery.6.2. Vaginal vault/apical suspension
Intravaginal slingplasties (IVS) using synthetic mesh
[49,13] has gained popularity as a less invasive
alternative to traditional procedures for vaginal
vault prolapse such as abdominal sacrocolpopexy,
sacrospinous ligament suspension, or uterosacralall surgery
up
s)
Cure rate,
anat. stage 0,
1, anterior vs.
posterior
Adverse
effects
Erosion
anterior vs.
posterior
75% 91.2% 0%
100% 93.8 DND 12.5%,
IN 3.2%, DYS
63% (increase)
13% 6.5%
94.7 DNSUI 5.4% 6.7% ST
91.5% ant. 93.9%
post. 88.2% comb.
DND 2.6%,
DNU 2.6%,
one rectovag.
fistula, 2 postop.
Hemorrhages
N500 ml
9.0%
95% 100% 3.8%
100% DNU 9.7%, UR 3.2% 3.2%
93.8% DND 0%, DNU 12.5%
l), DNSUI: de novo stress urinary incontinence, DNU: de novo
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plasties (anterior and posterior) are used despite a
lack of published data and based on the experi-
ences of only a few surgeons.
Petros [49] was the first to describe the posterior
IVS or infracoccygeal sacropexy. Women included in
this study (n =75) had at least a second degree
vaginal vault prolapse after hysterectomy, being
prolapse to the introitus. The success-rate was 94%
on follow-up (1.5—54 months). Mesh erosion oc-
curred in 5.6%.
Farnsworth [13] described his results on 93
patients with recurrent apical prolapse (at least
stage 2 or 3). The mean age was 65 years. Two
patients were lost for follow-up. During the study
period, he switched from nylon (n =49, Medhealth
Supplies, WA, USA) to a multifilament polypropyl-
ene mesh (Tyco Healthcare, USA) due to a 10%
rejection rate. This adverse effect was not
reported with the new synthetic material. At 12-
month follow-up, his anatomic success rate was
91%.
In contrast to the above results, Baessler et al.
[50] reported managing 19 women with complica-
tions following anterior and posterior intravaginal
slingplasty who were referred for sling removal.
For anterior slings, complications included mesh
infection, retropubic abscess, vesico-vaginal fistu-
la, pain and voiding difficulties. The main indica-
tion for the removal of the posterior intravaginal
slings was severe pain, especially during defeca-
tion and sexual intercourse. All these complica-
tions were alleviated by removal of the syntheticTable 6 Synthetic mesh used in vaginal vault suspension (
CON: constipation, DD: difficult defecation, DND: de novo
Author n/n
(follow-up)
Used material Technique
Petros, 2001 [49] 71 Nylon Posterior IVS
Farnsworth,
2002 [13]
91 Nylon (n =49)
Polypropylene
(n =44)
Posterior IVS
Lo et al.,
2005 [51]
15 Polypropylene SSLS
Rutman et al.,
2005 [52]
50 Polypropylene SULC complex
Shah et al.,
2004 [53]
29 not mentioned H-shaped mesh
Biertho et al.,
2004 [55]
34 Polypropylene Posterior IVS
Jordaan et al.,
2005 [56]
42/33 Polyglactin and
Prolene (Vypro)
Posterior IVSslings suggesting a significant risk of harm associ-
ated with the procedure leaving the risk vs.
benefit ratio of the procedure in doubt without
further trials.
The remainder of the techniques described in
the literature uses synthetic materials to rein-
force traditional apical suspensions. Lo et al. [51]
used polypropylene mesh for sacrospinous liga-
ment suspension in 15 patients with severe
recurrent vaginal vault or uterus prolapse. Their
mean age was 55 years, follow-up was 2.9 years.
Asymptomatic stage I recurrence was reported in
two patients (13.3%) while de novo dyspareunia
occurred in 25% and mesh erosion occurred in
6.7%. Rutman et al. [52] used polypropylene mesh
during uterosacral ligament suspension on 50
patients (mean age=67 years). After a follow-up
of 6 months two patients had apical recurrence
(4%). Erosion was occurred in one patient. Forty-
nine patients (98%) described improvement of
their symptoms. Shah et al. [53] described their
experience using mesh (not described) combined
with sacrospinous ligament suspension. The cure
rate was reported with 93.1%. At a follow-up of
24 weeks, perineal pain occurred in 3.4%, fre-
quency in 6.8%, urgency 6.9%, sacral pain in 13.7%
and dyspareunia in 60%. Similar to the criticism of
the IVS, the high rate of complications associated
with the use of mesh in apical repairs leaves their
application in doubt. In addition the anatomic
cure rates do not appear improved over tradi-
tional techniques [54].
Table 6 lists the reviewed articles of this section.UI: urge incontinence, SUI: stress urinary incontinence,
dyspareunia)
Mean
follow-up
(months)
Cure rate,
anat. (no
vault prolapse)
Adverse
effects
Erosion
1.5 to 54 94.0% 5.6%
12 91.0% Nylon
rejection
10%
34.8 100.0% DND 16.7% 6.7%
6 92.0% 1 unilateral
ureteral
obstruction
2.0%
25.14 93.1% DND 60%, sacral
pain 13.7%
0%
12 91.2% 1 bleeding
from an internal
hemorrhoid
2.9%
13 71.0% UI 42.9%, SUI
14.3%, CON 24%,
DD 14.3%,
DND 4.8%
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While the reduction of surgical failure rates in
vaginal reconstructive surgery is of critical impor-
tance, the addition of graft materials must be
shown to improve anatomical outcomes and at least
maintain if not improve lower urinary tract, bowel,
and sexual function as well as quality of life for the
patient. Unfortunately, the current literature does
not meet these criteria.
Normal vaginal function requires compliant,
flexible tissue and the ability to distend without
pain. These criteria make the use of graft
materials in the vagina more problematic than in
other areas such as inguinal or abdominal hernias.
The ideal material, flexible, yet durable, with low
morbidity, including erosion and pain has not been
found or at least adequately reported in the
literature. A monofilament, with a macropore
size, that remains flexible or dissolves after
appropriate collagen deposition has occurred
would seem appropriate for a synthetic graft.
The ideal biological graft would last long enough
to provide sufficient scaffolding for collagen
deposition, yet be flexible and have low erosion
rates. Without conducting well-powered random-
ized controlled trials, we are left with limited
reports of functional outcomes and complication
rates in evaluating the current grafts in vaginal
reconstructive surgery.
However, some conclusions are suggested by
the existing review. While there are clear differ-
ences between different graft materials, no one
material appears to be ideal. There may be a role
for the use of grafts in anterior vaginal wall
prolapse, although the two randomized controls
trials came to differing conclusions regarding its
application. The use of grafts in this area seems
to have a relatively low complication rate and
acceptable functional outcomes. The use of graft
materials for posterior wall prolapse is more
problematic due to disabling de novo functional
problems such as dyspareunia and pain with
defecation. The high rates of complications for
grafts in apical suspension procedures should
discourage practitioners from adopting its routine
use. Overall, the indiscriminate use of grafts in
vaginal reconstructive surgery is inappropriate at
this time.Acknowledgment
Funded by Deutsche Forschungsgemeinschaft
(DFG), HU1502/1-1.References
[1] Birch C. The use of prosthetics in pelvic reconstructive
surgery. Best Pract Res Clin Obstet Gynaecol 2005;19:
979–91.
[2] Maher C, Baessler K. Surgical management of anterior
vaginal wall prolapse: an evidencebased literature review.
Int Urogynecol J Pelvic Floor Dysfunct 2005 (May) [Elec-
tronic Publication].
[3] Maher C, Baessler K. Surgical management of posterior
vaginal wall prolapse: an evidence-based literature review.
Int Urogynecol J Pelvic Floor Dysfunct 2006;17:86–8.
[4] Altman D, Mellgren A, Zetterstrom J. Rectocele repair
using biomaterial augmentation: current documentation
and clinical experience. Obstet Gynecol Surv 2005;60:
753–60.
[5] Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ
prolapse in the United States, 1979—1997. Am J Obstet
Gynecol 2003;188:108–15.
[6] Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL.
Epidemiology of surgically managed pelvic organ pro-
lapse and urinary incontinence. Obstet Gynecol 1997;89:
501–6.
[7] Stanton SL. Mid-urethral tapes: which? Review of available
commercial mid-urethral tapes for the correction of stress
incontinence. BJOG 2004;111(Suppl 1):41–5.
[8] Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G,
Weber AM, et al. Pelvic floor disorders network. Abdominal
sacrocolpopexy: a comprehensive review. Obstet Gynecol
2004;104:805–23.
[9] Fenner DE. New surgical mesh. Clin Obstet Gynecol 2000;
43:650–8.
[10] Cumberland VH. A preliminary report on the use of
prefabricated nylon weave in the repair of ventral hernia.
Med J Aust 1952;1:143–4.
[11] Scales JT. Materials for hernia repair. Proc R Soc Med 1953;
46:647–52.
[12] Amid PK. Classification of biomaterials and their related
complications in abdominal wall surgery. Hernia 1997;
1:15–21.
[13] Farnsworth BN. Posterior intravaginal slingplasty (infra-
coccygeal sacropexy) for severe posthysterectomy vaginal
vault prolapse—a preliminary report on efficacy and
safety. Int Urogynecol J Pelvic Floor Dysfunct 2002;
13:4–8.
[14] Dietz HP, Vancaillie P, Svehla M, Walsh W, Steensma AB,
Vancaillie TG. Mechanical properties of urogynecologic
implant materials. Int Urogynecol J Pelvic Floor Dysfunct
2003;14:239–43.
[15] Sand PK, Koduri S, Lobel RW, Winkler HA, Tomezsko J,
Culligan PJ, et al. Prospective randomized trial of poly-
glactin 910 mesh to prevent recurrence of cystoceles and
rectoceles. Am J Obstet Gynecol 2001;184:1357–62 [dis-
cussion 1362–1364].
[16] Weber AM, Walters MD, Piedmonte MR, Ballard LA. Anterior
colporrhaphy: a randomized trial of three surgical techni-
ques. Am J Obstet Gynecol 2001;185:1299–304 [discussion
1304–1306].
[17] Bump RC, Mattiasson A., Bø K, Brubaker LP, De Lancey JO,
Klarskov P, et al. The standardization of terminology of
female pelvic organ prolapse and pelvic floor dysfunction.
Am J Obstet Gynecol 1996;175:10–7.
[18] Yan A, Anne M, Karine A, Vanessa F, Christophe P, Anne T,
et al. Cystocele repair by a synthetic vaginal mesh secured
anteriorly through the obturator foramen. Eur J Obstet
Gynecol Reprod Biol 2004;115:90–4.
The use of graft materials in vaginal pelvic floor surgery 287[19] Rodriguez LV, Bukkapatnam R, Shah SM, Raz S. Trans-
vaginal paravaginal repair of high-grade cystocele central
and lateral defects with concomitant suburethral sling:
report of early results, outcomes, and patient satisfaction
with a new technique. Urology 2005 (Nov);66(5 Suppl):
57–65.
[20] Flood CG, Drutz HP, Waja L. Anterior colporrhaphy rein-
forced with Marlex mesh for the treatment of cystoceles.
Int Urogynecol J Pelvic Floor Dysfunct 1998;9:200–4.
[21] Cronje HS, Prollius A. Vaginal anterior colposuspension
(VACS) for cystocele. Int J Gynecol Obstet 2004;87:46–7.
[22] De Tayrac R, Gervaise A, Fernandez H. Cystocele repair by
the vaginal route with a tension-free sub-bladder prosthe-
sis. J Gynecol Obstet Biol Reprod (Paris) 2002;31:597–9.
[23] Palma P, Rane A, Riccetto C, Herrmann V, Dambros M,
Tarazona A. Transobturator correction of cystocele. Actas
Urol Esp 2005;29(1):89–92.
[24] De Tayrac R, Gervaise A, Chauveaud A, Fernandez H.
Tension-free polypropylene mesh for vaginal repair of
anterior vaginal wall prolapse. J Reprod Med 2005;50:
75–80.
[25] Bader G, Fauconnier A, Roger N, Heitz D, Ville Y. Cystocele
repair by vaginal approach with a tension-free transversal
polypropylene mesh. Technique and results. Gynecol Obstet
Fertil 2004;32:280–4.
[26] Migliari R, De Angelis M, Madeddu G, Verdacchi T. Tension-
free vaginal mesh repair for anterior vaginal wall prolapse.
Eur Urol 2000;38:151–5.
[27] Migliari R, Usai E. Treatment results using a mixed fiber
mesh in patients with grade IV cystocele. J Urol 1999;161:
1255–8 [Comment in: J Urol 1999;162:1388].
[28] Julian TM. The efficacy of Marlex mesh in the repair of
severe, recurrent vaginal prolapse of the anterior mid-
vaginal wall. Am J Obstet Gynecol 1996;175:1472–5.
[29] Gandhi S, Goldberg RP, Kwon C, Koduri S, Beaumont JL,
Abramov Y, et al. A prospective randomized trial using
solvent dehydrated fascia lata for the prevention of
recurrent anterior vaginal wall prolapse. Am J Obstet
Gynecol 2005;192:1649–54.
[30] Frederick RW, Leach GE. Cadaveric prolapse repair with
sling: intermediate outcomes with 6 months to 5 years of
follow-up. J Urol 2005;173:1229–33.
[31] Groutz A, Chaikin DC, Theusen E, Blaivas JG. Use of
cadaveric solvent-dehydrated fascia lata for cystocele
repair-preliminary results. Urology 2001;58:179–83.
[32] Chung SY, Franks M, Smith CP, Lee JY, Lu SH, Chancellor M.
Technique of combined pubovaginal sling and cystocele
repair using a single piece of cadaveric dermal graft.
Urology 2002;59:538–41.
[33] Leboeuf L, Miles RA, Kim SS, Gousse AE. Grade 4 cystocele
repair using four-defect repair and porcine xenograft
acellular matrix (Pelvicol): outcome measures using SEAPI.
Urology 2004;64:282–6.
[34] Gomelsky A, Rudy DC, Dmochowski RR. Porcine dermis
interposition graft for repair of high grade anterior
compartment defects with or without concomitant pelvic
organ prolapse procedures. J Urol 2004;171:1581–4.
[35] Clemons JL, Myers DL, Aguilar VC, Arya LA. Vaginal para-
vaginal repair with an AlloDerm graft. Am J Obstet Gynecol
2003;189:1612–8 [discussion 1618–1619].
[36] Salomon LJ, Detchev R, Barranger E, Cortez A, Callard P,
Darai E. Treatment of anterior vaginal wall prolapse with
porcine skin collagen implant by the transobturator route:
preliminary results. Eur Urol 2004;45:219–25.
[37] Kohli N, Miklos JR. Dermal graft-augmented rectocele
repair. Int Urogynecol J Pelvic Floor Dysfunct 2003;14:
146–9 [Electronic publication 2003 Feb 13].[38] Lim YN, Rane A, Muller R. An ambispective observational
study in the safety and efficacy of posterior colporrhaphy
with composite Vicryl-Prolene mesh. Int Urogynecol J Pelvic
Floor Dysfunct 2005;16:126–231 [discussion 131. Electonic
publication 2004 Sep 25. Erratum in: Int Urogynecol J Pelvic
Floor Dysfunct. 2005;16:170].
[39] Oster S, Astrup A. A new vaginal operation for recurrent and
large rectocele using dermis transplant. Acta Obstet
Gynecol Scand 1981;60:493–5.
[40] Altman D, Zetterstrom J, Lopez A, Anzen B, Falconer C,
Hjern F, et al. Functional and anatomic outcome after
transvaginal rectocele repair using collagen mesh: a
prospective study. Dis Colon Rectum 2005;48:1233 –41
[discussion 1241–1242; author reply 1242].
[41] de Tayrac R, Picone O, Chauveaud-Lambling A, Fernandez
H. A 2-year anatomical and functional assessment of
transvaginal rectocele repair using a polypropylene mesh.
Int Urogynecol J Pelvic Floor Dysfunct 2005.
[42] Milani R, Salvatore S, Soligo M, Pifarotti P, Meschia M,
Cortese M. Functional and anatomical outcome of anterior
and posterior vaginal prolapse repair with prolene mesh.
BJOG 2005;112:107–11.
[43] Cosson M, Caquant F, Collinet P, Rosenthal C, Clave H,
Debodinance P. et al. Prolift (Mesh (Gynecare) For Pelivc
Organ Prolapse. Surgical Treatment Using The TVM Group
Technique: A etrospective Study Of 96 Women Of Less Than
50 Years Old. ICS 2005 Presentation.
[44] Cosson M, Caquant F, Collinet P, Rosenthal C, Clave H,
Debodinance P. et al. Prolift (Mesh (Gynecare) For Pelivc
Organ Prolapse. Surgical Treatment Using The TVM Group
Technique: A Retrospective Study Of 687 Pationes. ICS 2005
Presentation.
[45] Dwyer PL, O’Reilly BA. Transvaginal repair of anterior and
posterior compartment prolapse with Atrium polypropylene
mesh. BJOG 2004;111:831–6.
[46] Adhoute F, Soyeur L, Pariente JL, Le Guillou M, Ferriere JM.
Use of transvaginal polypropylene mesh (Gynemesh) for the
treatment of pelvic floor disorders in women. Prospective
study in 52 patients. Prog Urol 2004 (Apr);14(2):192–6.
[47] Borrell Palanca A, Chicote Perez F, Queipo Zaragoza JA,
Beltran Meseguer JF, Esteve Claramunt J, Pastor Sempere F.
Cystocele repair with a polypropylene mesh: our experi-
ence. Arch Esp Urol 2004;57:391–6.
[48] Canepa G, Ricciotti G, Introini C, Vigliercio G, Puppo P.
Horseshoe-shaped marlex mesh for the treatment of
pelvic floor prolapse. Eur Urol 2001;39(Suppl 2):23–6
[discussion 27].
[49] Petros PE. Vault prolapse II: restoration of dynamic vaginal
supports by infracoccygeal sacropexy, an axial day-case
vaginal procedure. Int Urogynecol J Pelvic Floor Dysfunct
2001;12:296–303.
[50] Baessler K, Hewson AD, Tunn R, Schuessler B, Maher CF.
Severe mesh complications following intravaginal sling-
plasty. Obstet Gynecol 2005;106:713–6.
[51] Lo TS, Horng SG, Huang HJ, Lee SJ, Liang CC. Repair of
recurrent vaginal vault prolapse using sacrospinous liga-
ment fixation with mesh interposition and reinforcement.
Acta Obstet Gynecol Scand 2005;84:992–5.
[52] Rutman MP, Deng DY, Rodriguez L, Raz S. Repair of vaginal
vault prolapse and pelvic floor relaxation using polypropyl-
ene mesh: 3. Neurourol Urodyn 2005;24:654–8.
[53] Shah DK, Paul EM, Rastinehad AR, Eisenberg ER, Badlani
GH. Short-term outcome analysis of total pelvic recon-
struction with mesh: the vaginal approach. J Urol 2004;
171:261–3.
[54] Morley GW, DeLancey JO. Sacrospinous ligament fixation
for eversion of the vagina. Am J Obstet Gynecol 1988;
M. Huebner et al.288158:872–81 [Comment in: Am J Obstet Gynecol. 1990;162:
295–296].
[55] Biertho I, Dallemagne B, Dewandre JM, Markiewicz S,
Monami B, Wahlen C, et al. Intravaginal slingplasty: short
term results. Acta Chir Belg 2004;104:700–4.[56] Jordaan DJ, Prollius A, Cronje HS, Nel M. Posterior
intravaginal slingplasty for vaginal prolapse. Int Urogy-
necol J Pelvic Floor Dysfunct 2005;27:1–4 [Electronic
Publication].
